TSLA

309.02

-0.22%↓

NKE

74.43

-0.6%↓

ORLY

102.26

+0.84%↑

HLT

260.19

-0.82%↓

AZO

4,012

+1.18%↑

TSLA

309.02

-0.22%↓

NKE

74.43

-0.6%↓

ORLY

102.26

+0.84%↑

HLT

260.19

-0.82%↓

AZO

4,012

+1.18%↑

TSLA

309.02

-0.22%↓

NKE

74.43

-0.6%↓

ORLY

102.26

+0.84%↑

HLT

260.19

-0.82%↓

AZO

4,012

+1.18%↑

TSLA

309.02

-0.22%↓

NKE

74.43

-0.6%↓

ORLY

102.26

+0.84%↑

HLT

260.19

-0.82%↓

AZO

4,012

+1.18%↑

TSLA

309.02

-0.22%↓

NKE

74.43

-0.6%↓

ORLY

102.26

+0.84%↑

HLT

260.19

-0.82%↓

AZO

4,012

+1.18%↑

Search

Sylvamo Corp.

Suletud

SektorTarbekaubad (tsüklilised)

46.81 2.12

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

45.06

Max

47.18

Põhinäitajad

By Trading Economics

Sissetulek

-54M

27M

Müük

-149M

821M

P/E

Sektori keskmine

7.068

35.993

Aktsiakasum

0.68

Dividenditootlus

3.4

Kasumimarginaal

3.289

Töötajad

6,500

EBITDA

-81M

84M

Soovitused

By TipRanks

Soovitused

Müü

12 kuu keskmine prognoos

+38.12% upside

Dividendid

By Dow Jones

Dividenditootlus

Sektori keskmine

3.40%

2.95%

Järgmine tulemuste avaldamine

8. aug 2025

Järgmine dividendimakse kuupäev

16. okt 2025

Järgmine aktsia dividendi kuupäev (ex-date)

2. okt 2025

Turustatistika

By TradingEconomics

Turukapital

-490M

2B

Eelmine avamishind

44.69

Eelmine sulgemishind

46.81

Uudiste sentiment

By Acuity

50%

50%

145 / 373 Pingereas Consumer cyclical

Tehniline skoor

By Trading Central

Kindlus

Weak Bearish Evidence

Sylvamo Corp. Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

4. aug 2025, 21:42 UTC

Tulu
Omandamised, ülevõtmised, äriostud

Cabot to Acquire Mexico Carbon Manufacturing From Bridgestone

4. aug 2025, 21:21 UTC

Tulu
Suurimad hinnamuutused turgudel

Vertex Stock Falls After Pain-Drug Setback, Despite Stronger 2Q Earnings -- Update

4. aug 2025, 20:45 UTC

Tulu

Vertex Pharmaceuticals Swings to 2Q Profit as Sales Climb

4. aug 2025, 19:15 UTC

Suurimad hinnamuutused turgudel

TransMedics Group Shares Rise on FDA Approval for Clinical Trial

4. aug 2025, 23:41 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

4. aug 2025, 23:41 UTC

Market Talk

Nikkei May Rise on Fed Stimulus Hopes

4. aug 2025, 23:28 UTC

Market Talk

Global Equities Roundup: Market Talk

4. aug 2025, 23:28 UTC

Market Talk

Gold Seen Stuck in Range as Investors Await Fed's Next Move -- Market Talk

4. aug 2025, 21:30 UTC

Tulu

Palantir Stock Jumps. Earnings Blew Past Wall Street's Expectations. -- Barrons.com

4. aug 2025, 21:21 UTC

Tulu
Omandamised, ülevõtmised, äriostud

Berkshire Stock Was Hammered Monday. It's Like 1999 Again. -- Barrons.com

4. aug 2025, 21:18 UTC

Tulu

Palantir Stock Jumps. Earnings Blew Past Wall Street's Expectations. -- Barrons.com

4. aug 2025, 20:25 UTC

Market Talk

India Hits Back Over Russian Oil Purchases -- Market Talk

4. aug 2025, 20:25 UTC

Tulu

Transocean 2Q Loss $938M >RIG

4. aug 2025, 20:25 UTC

Tulu

Transocean 2Q Loss/Shr $1.06 >RIG

4. aug 2025, 20:18 UTC

Tulu

Palantir Stock Jumps. Earnings Blew Past Wall Street's Stratospheric Expectations. -- Barrons.com

4. aug 2025, 20:15 UTC

Tulu

Vertex Pharma: Guidance Includes Immaterial Cost Impact From Tariffs in 2025 Based on Currently Known Tariff Rates and Regulations >VRTX

4. aug 2025, 20:14 UTC

Tulu

Vertex Pharmaceuticals Reiterated FY25 Fincl Guidance >VRTX

4. aug 2025, 20:14 UTC

Tulu

Vertex Pharma: Mark Bunnage, D.Phil., SVP of Global Research, to Assume Role of CSO Effective Feb 1, 2026 >VRTX

4. aug 2025, 20:14 UTC

Tulu

Vertex Pharma: David Altshuler, Chief Scientific Officer, Intends to Retire Aug 1, 2026 >VRTX

4. aug 2025, 20:13 UTC

Tulu

Vertex Pharmaceuticals Backs FY25 Rev $11.85B-$12B >VRTX

4. aug 2025, 20:09 UTC

Tulu

Viper Energy: Initiating Avg Daily Production Guidance for 3Q of 46,000 to 49,000 Bo/d (86,000 to 92,000 Boe/d) >VNOM

4. aug 2025, 20:06 UTC

Tulu

Palantir Earnings Blow Past Wall Street's Stratospheric Expectations -- Barrons.com

4. aug 2025, 20:01 UTC

Tulu

Vertex Pharmaceuticals 2Q Net $1.03B >VRTX

4. aug 2025, 20:01 UTC

Tulu

Vertex Pharmaceuticals 2Q Adj EPS $4.52 >VRTX

4. aug 2025, 20:01 UTC

Tulu

Vertex Pharmaceuticals 2Q Rev $2.96B >VRTX

4. aug 2025, 20:01 UTC

Tulu

Vertex Pharmaceuticals 2Q EPS $3.99 >VRTX

4. aug 2025, 19:41 UTC

Market Talk

U.S. Natural Gas Futures Settle Lower -- Market Talk

4. aug 2025, 19:28 UTC

Market Talk

U.S. Hiring Expected to Recover Once Uncertainty Dissipates -- Market Talk

4. aug 2025, 19:07 UTC

Market Talk

Oil Extends Losing Streak As OPEC+ to Raise Output -- Market Talk

4. aug 2025, 18:27 UTC

Market Talk

Gold Climbs on Rate Cut Speculation -- Market Talk

Võrdlus sarnastega

Hinnamuutus

Sylvamo Corp. Prognoos

Hinnasiht

By TipRanks

38.12% tõus

12 kuu keskmine prognoos

Keskmine 62.5 USD  38.12%

Kõrge 64 USD

Madal 61 USD

Põhineb 2 Wall Streeti analüütiku instrumendi Sylvamo Corp. 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Müü

2 ratings

0

Osta

1

Hoia

1

Müü

Tehniline skoor

By Trading Central

59.57 / 60.23Toetus ja vastupanu

Lühikene perspektiiv

Weak Bearish Evidence

Keskpikk perspektiiv

Bearish Evidence

Pikk perspektiiv

Bearish Evidence

Sentiment

By Acuity

145 / 373 Pingereas Tarbekaubad (tsüklilised)

Uudiste sentiment

Neutral

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Keskmine

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Sylvamo Corp.

Sylvamo Corporation produces and markets uncoated freesheet for cutsize, offset paper, and pulp in Latin America, Europe, and North America. The company operates through Europe, Latin America, and North America segments. The Europe segment offers copy, tinted, and colored laser printing paper under REY Adagio and Pro-Design brands; and graphic and high-speed inkjet printing papers under the brand Jetstar; as well as produces uncoated freesheet papers. The Latin America segment focuses on uncoated freesheet paper under Chamex, Chamequinho and Chambril brands, as well as produces HP papers. This segment also operates integrated mills and non-integrated mills. The North America segment offers imaging, commercial printing, and converting papers, as well as uncoated papers under Hammermill, Springhill, Williamsburg, Accent, DRM and Postmark brand names. It distributes its products through a variety of channels, including retail merchants, e-commerce, agents, resellers, and paper distributors. The company was founded in 1898 and is headquartered in Memphis, Tennessee.